REGISTERED
on 05 Jul 2022
Last Applicant/ Owned by
170 Park Avenue
Florham Park
NJ
07932
Serial Number
97265928 filed on 14th Feb 2022
Registration Number
6782541 registered on 05th Jul 2022
Correspondent Address
Camille M. Miller
Filing Basis
1. use application currently
Disclaimer
NO DATA
CELULARITY IMPACT
Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting Read More
Classification Information
Class [040]
Treatment & Processing of Materials Services
Manufacturing services of biopharmaceuticals and gene and cell therapy products, namely, genetically engineered tissues for others; manufacturing services for others in the fields of mammalian cell banks, plasmids, purified mitochondria, cell lysates; production of cells for others; custom manufacturing of cells for others; advanced cell manufacturing for others; manufacturing process consulting
First Use Date in General
29th Mar 2019
First Use Date in Commerce
29th Mar 2019
Class [042]
Computer & Software Services & Scientific Services
Research, development and testing services in the fields of genomics, biotechnology and pharmaceuticals, namely, collection, testing, processing, preservation, storage and retrieval of cells and biological tissue, namely, blood, stem cells, umbilical cords, umbilical cord blood, and placental tissue; laboratory research services in the field of genomics, biotechnology and pharmaceuticals consisting of collection, testing, processing, preservation, storage and retrieval of bioengineered cells, human allograft tissue made from human umbilical cords and human placentas, human amniotic membrane and human chorionic membrane, human collagen and extracellular matrix compositions; providing a website featuring information in the field of medical research relating to banking stem cells and cord blood banking; biosourcing of clinically accessible, immune-tolerant human stem and progenitor and other postpartum placenta-derived cell populations and tissues for medical research; scientific and technological services, namely, scientific research, analysis, and testing in the field of genomics, biotechnology, and pharmaceuticals; medical research to find methods to restore the structure and function of damaged or diseased tissues and organs, including wound care, reconstructive medicine, whole organ and tissue regeneration and renewal; medical research regarding emergent cell therapies; medical research regarding allogeneic immunotherapy; providing on-line information, news and commentary in the field of medical research relating to the foregoing; research, development and testing services for others in the fields of genomics, biotechnology and pharmaceuticals
First Use Date in General
29th Mar 2019
First Use Date in Commerce
29th Mar 2019
Mark Details
Serial Number
No 97265928
Mark Type
No Service Mark
Attorney Docket Number
No CLTY0531US2
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 05th Jul 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 05th Jul 2022 | REGISTERED-PRINCIPAL REGISTER |
| 19th Apr 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Apr 2022 | PUBLISHED FOR OPPOSITION |
| 30th Mar 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 15th Mar 2022 | ASSIGNED TO LIE |
| 11th Mar 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 11th Mar 2022 | EXAMINER'S AMENDMENT ENTERED |
| 11th Mar 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 11th Mar 2022 | EXAMINERS AMENDMENT E-MAILED |